BusinessMEDAMACS 1-YEAR STUDY RESULTS ON ADVANCED HEART FAILURE INDICATE CLINICIANS SHOULD EXPAND VAD THERAPY TO THOSE PREVIOUSLY THOUGHT AS ‘TOO HEALTHY’By Nasdaq OMXApr 8, 2017, 5:45 PM UTC
BusinessENDURANCE SUPPLEMENTAL ONE-YEAR HVAD RESULTS SHOW DECREASED RATE OF STROKE COMPARED TO ENDURANCE TRIALBy Nasdaq OMXApr 5, 2017, 6:35 PM UTC
